StockVS

HCM IV Acquisition Corp. (HACQU) 股票分析

金融服务

HCM IV Acquisition Corp.

$10.07

+$0.00 (+0.00%)

最后更新: 2026年5月26日

价格走势

分析

公司概述

HCM IV Acquisition Corp. (HACQU) is a shell company incorporated in 2025 and headquartered in Stamford, Connecticut, which primarily focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company operates within the Financial Services sector and specifically within the Shell Companies industry, a classification that indicates the entity has not yet engaged in its primary operating activities or has been spun off from a parent organization without independent operations. Regarding its scale, the company currently has a market capitalization listed as N/A, annual revenue figures listed as N/A, and an employee count listed as N/A. The absence of quantifiable market cap and revenue figures for a shell company operating in this industry typically indicates that the entity exists as a vehicle for a future business combination rather than as an operating business with established earnings or market valuation at this stage. Consequently, the lack of historical revenue and employee data reflects the transitional nature of the entity's existence prior to completing a merger agreement.

财务健康

The financial statements for HCM IV Acquisition Corp. show a Net Income (TTM) of $-178,965, while Revenue (TTM) and EBITDA are both listed as N/A. The significant gap between the reported net income loss and the unavailable revenue figures reveals that the company's cost structure is currently driven by incorporation expenses and administrative costs rather than operational expenditures related to revenue generation. Free Cash Flow is listed as N/A, which for a shell company implies that cash flow from operations has not yet been established or is insufficient to meet standard reporting thresholds, indicating limited financial flexibility at this specific moment in time. The company reports a Gross Margin of 0.0%, an Operating Margin of 0.0%, and a Profit Margin of 0.0%, figures that indicate the entity is not yet generating profit from sales or operations and is incurring costs without corresponding revenue streams. In terms of balance sheet leverage, the company holds N/A in cash and carries $0 in debt, resulting in a Debt to Equity ratio that is N/A, which suggests a neutral leverage position typical for SPACs before a deal closes. However, the Current Ratio stands at 0.13, a metric that indicates the company possesses significantly less current assets than current liabilities, suggesting potential short-term liquidity constraints. Furthermore, Return on Equity and Return on Assets are both listed as N/A, metrics that reveal that management effectiveness cannot be evaluated using standard return metrics until the company completes a business combination and begins generating assets and equity value.

估值评估

The trailing twelve-month P/E ratio and forward P/E for HCM IV Acquisition Corp. are both listed as N/A, a status that implies there is no established earnings trajectory for valuation comparison at this time. The Price to Book ratio is reported at -2507.50, a figure that indicates the market price is significantly detached from the company's tangible book value, a common characteristic for shell companies where the book value is often negative due to accumulated losses or organizational costs. Price to Sales and EV/EBITDA are also listed as N/A, suggesting that traditional multiple-based valuation methods are not applicable until the company generates revenue or EBITDA upon merger. The stock's trading range is bounded by a 52-Week High of $10.15 and a 52-Week Low of $10.02, indicating that the current price sits within a very narrow band close to the 52-week low relative to the high. The Beta is listed as N/A, which means there is insufficient historical volatility data relative to the broader market to calculate a standard beta coefficient for this pre-merger entity.

Growth & Income

Revenue Growth (YoY) and Earnings Growth (YoY) are both listed as N/A, reflecting the fact that the company is not yet an operating entity with a history of growth rates to compare. Since the company does not pay dividends, the Dividend Yield and Payout Ratio are listed as N/A, which implies that any future earnings generated post-merger will likely be reinvested into the business rather than distributed to shareholders. The company's overall growth and income profile is currently characterized by a lack of historical financial performance data, as it exists solely as a vehicle for a future business combination.

同行比较

HCM IV Acquisition Corp. (HACQU) 在壳公司行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
HCM IV Acquisition Corp. HACQU N/A N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

壳公司行业平均市盈率为82.8倍。HCM IV Acquisition Corp.的市盈率为N/A。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于HCM IV Acquisition Corp.

HCM IV Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in Stamford, Connecticut.

公司简介以英文显示。

关键指标

市值
N/A
市盈率
N/A
52周最高
$10.15
52周最低
$10.01
平均成交量
8.65K

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
United States